chartexchange

RNAC
Cartesian Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:56 PM EST
6.30USD+3.023%(+0.18)170,209
After-hoursNov 18, 2026 4:00:30 PM EST
6.30USD-0.079%(-0.00)
Loading…
Loading…
192.32M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Watertown, Massachusetts, USA
Previous Close
$6.12
Beta
1.37
52-Week High
$11.00 2026-06-24
52-Week Low
$5.60 2026-03-27
SMA 50
$6.97
SMA 200
$7.60
Avg. Vol 10D
172,181
Avg. Vol 30D
140,802
Avg. Vol 90D
133,878
Relative Vol
1.21
11.73M
0.6800%
1,641
Apr 5, 2024 · 1-for-30 (reverse)
RNAC Profile

selecta biosciences, inc. is a clinical-stage biopharmaceutical company that is focused on unlocking the full potential of biologic therapies by mitigating unwanted immune responses. selecta plans to combine its tolerogenic synthetic vaccine particles (svp™) to a range of biologics for rare and serious diseases that require new treatment options. the company's current proprietary pipeline includes svp-enabled enzyme, oncology and gene therapies. sel-212, the company's lead candidate in phase 2, is being developed to treat severe gout patients and resolve their debilitating symptoms, including flares and gouty arthritis. selecta's sel-403 product candidate, a combination therapy consisting of svp-rapamycin and lmb-100, recently entered a phase 1 trial in 2018 for the treatment of patients with malignant pleural or peritoneal mesothelioma. selecta's proprietary gene therapy product candidates are being developed for rare inborn errors of metabolism and have the potential to enable repeat

RNAC Performance
PeriodPriceDateChangeBeta
1W6.362026-11-12-0.79%3.536
1M6.082026-10-19+3.70%0.679
3M10.492026-08-19-39.90%0.616
6M6.092026-05-19+3.53%0.702
1Y7.152025-11-19-11.82%1.369
2Y17.552024-11-19-64.07%—
5Y29.092023-11-15-78.32%1.712
RNAC Stock Summary

Cartesian Therapeutics, Inc. Common Stock (NASDAQ:RNAC) stock price today is $6.31, and today's volume is 170,209. RNAC is up 3.023% today. The 30 day average volume is 140,802. RNAC market cap is $192.32M with 30.50M shares outstanding.